NewGenIvf Group Limited - SIC # 8081 -

Ticker Exchange SIC # Website Latest Ticker
NIVF Nasdaq 8081 newgenivf.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for NewGenIvf Group Limited

NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia - May 7th, 2025 12:00 pm
NewGenIVF Announces Reverse Stock Split - May 1st, 2025 2:25 pm
NewGen Filed 2024 Annual Report on Form 20-F - Apr 22nd, 2025 1:26 pm
NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth - Apr 3rd, 2025 12:30 pm
NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness - Mar 31st, 2025 1:09 pm
NewGenIvf Provides Update on Proposed Reverse Merger with European Wellness Holdings and Completion of Strategic Acquisition of MicroSort Reproductive Technology - Mar 7th, 2025 4:30 pm
NewGen and BOBCARE Announce Strategic Collaboration to Expand Fertility Services in Kyrgyzstan - Mar 3rd, 2025 12:00 pm
NewGen Regains Compliance with Nasdaq Minimum Bid Price Requirement and Announces Listing Transfer to the Nasdaq Capital Market - Feb 28th, 2025 12:00 pm
NewGen Issues Clarification on Press Release Titled “NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director” dated February 20, 2025 - Feb 20th, 2025 9:30 pm
NewGen Receives Continued Nasdaq Listing Approval and Announces New Business Development Director - Feb 20th, 2025 11:00 am
NewGen Announces Reverse Stock Split - Jan 31st, 2025 1:00 pm
NewGen Announces Strategic Acquisition of MicroSort Reproductive Technology - Jan 21st, 2025 11:00 am
NewGen Launches Innovative Lifetime Egg Freezing Service to Address Growing Market Need in Asia - Jan 13th, 2025 11:00 am
NewGen Progresses Reverse Merger Plans with Engagement of Legal Teams and Updated Timeline - Dec 23rd, 2024 12:30 pm
NewGen Engages OSL to Execute Strategic Investment in Digital Assets - Dec 19th, 2024 12:00 pm
NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings - Dec 11th, 2024 12:00 pm
NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance - Nov 22nd, 2024 12:00 pm
NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million - Nov 18th, 2024 12:00 pm
NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price - Oct 14th, 2024 12:00 pm
NewGenIvf Announces Filing of 2023 Annual Report with the SEC - Aug 21st, 2024 11:00 am